viewCanAlaska Uranium Ltd

CanAlaska starts drilling Bayswater’s Collins Bay Extension Project, east of Cameco mine


CanAlaska Uranium (TSX-V: CVV) has commenced drilling at Bayswater Uranium’s (TSX-V:BYU, OTC:BYSWF) Collins Bay Extension Project, which is located only 8 kilometres east of Cameco’s (TSX:CCO) Collins Bay-Eagle Point uranium mine.

CanAlaska Uranium, operator of the Collins Bay Extension Project, plans to drill at least five holes into shallow targets at Fife Island, which have been previously identified through geochemical sampling, airborne VTEM and magnetic surveys and some drilling by Bayswater Uranium.  Drilling will also focus on a new target south-west of Blue Island, which was first identified by Bayswater in 2007.

CanAlaska can earn up to 51% in the Collins Bay Extension Project by expending CDN$4 million over 5 years and will also issue 500,000 shares to Bayswater. CanAlaska can up its interest in the project to 70% by completed a further CDN$2 million in exploration over an additional three years.

George Leary, president of Bayswater stated, "We are excited about the drill follow up of an historical drill intercept after re-evaluation by CanAlaska's knowledgeable technical team. The second new drill target, defined by state-of-art VTEM and gravity surveys which indicate a conductor in coincidence with an alteration system and favourable structure, has the size, geological and geophysical character and proximity to known uranium deposits that are highly favourable indications of a significant target. We look forward to the results of drilling on both of these targets."

CanAlaska is currently drill-testing the ‘Vic Zone’ on the northern end of Fife Island.

Quick facts: CanAlaska Uranium Ltd

Price: 0.175 CAD

Market: TSX-V
Market Cap: $10.08 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: PetVivo preparing to bring their lead medical device Kush to...

PetVivo (OTCQB: PETV) CEO John Lai joined Steve Darling from Proactive to discuss the company that is developing a treatment for osteoarthritis is horses and dogs. The company’s lead medical device is called Kush and according to PetVivo it mimics cartilage. Lai tells Proactive about the size...

4 hours, 28 minutes ago

2 min read